CNTA
Centessa Pharmaceuticals plc
NASDAQ · Healthcare · Biotechnology · GB
$40.50
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 12.86x
- Price / sales
- —
- Price / cash flow
- -30.01x
Enterprise value
- Enterprise value
- $6.0B
- EV / sales
- —
- EV / EBITDA
- -23.02x
- EV / EBIT
- -23.36x
- Market cap
- $6.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026